General Information of Drug (ID: DM6R34M)

Drug Name
N-{4 Drug Info
Synonyms
LGB321; CHEMBL3105022; 1210417-75-6; N-{4-[(3r,4r,5s)-3-Amino-4-Hydroxy-5-Methylpiperidin-1-Yl]pyridin-3-Yl}-6-(2,6-Difluorophenyl)-5-Fluoropyridine-2-Carboxamide; N-[4-[(3R,4R,5S)-3-amino-4-hydroxy-5-methylpiperidin-1-yl]pyridin-3-yl]-6-(2,6-difluorophenyl)-5-fluoropyridine-2-carboxamide; NVP-LGB321; GTPL9367; SCHEMBL1711617; BDBM106896; EX-A1572; AMX10208; SB19299; n-(4-((3r,4r,5s)-3-amino-4-hydroxy-5-methylpiperidin-1-yl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide; US8592455, 96; LGB321 1210415-88-5; N-{4
Cross-matching ID
PubChem CID
46179018
TTD Drug ID
DM6R34M

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Drug(s) Targeting PIM-3 protein kinase (PIM3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
US9682991, 23 DMGTIP6 N. A. N. A. Patented [2]
US8889696, Staurosporine DMSYUHK N. A. N. A. Patented [3]
US8829193, 3 DM5ZGK3 N. A. N. A. Patented [4]
BDBM50061601 DMQ4TUE N. A. N. A. Patented [5]
US9580418, Example 8 DMGH9B3 N. A. N. A. Patented [6]
BDBM50061608 DM3MRD9 N. A. N. A. Patented [5]
US8481586, 15 DMFEUMZ N. A. N. A. Patented [7]
US9434725, 315 DM316FB N. A. N. A. Patented [8]
BDBM50061612 DMM8IDC N. A. N. A. Patented [5]
US8669361, 102 DM4G3OC N. A. N. A. Patented [9]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
PIM-3 protein kinase (PIM3) TTCGOIN PIM3_HUMAN Inhibitor [1]

References

1 Kinase inhibitors and methods of their use. US8592455.
2 Tricyclic compounds for use as kinase inhibitors. US9682991.
3 Substituted pyrido[2,3-d]pyrimidin-7(8H)-ones and therapeutic uses thereof. US8889696.
4 PIM kinase inhibitors and methods of their use. US8829193.
5 Azole compounds as PIM inhibitors. US9321756.
6 Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors. US9580418.
7 Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors. US8481586.
8 5-azaindazole compounds and methods of use. US9434725.
9 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use. US9573943.